Exploration of sex differences in Rhes effects in dopamine mediated behaviors

Neuropsychiatric Disease and Treatment

Volumn 7, Issue 1, 2011, Pages 697-706

  Quintero, Gabriel C ^a,b   Spano, Daniela ^c  

^a INSTITUTO DE INVESTIGACIONES CIENTÍFICAS Y SERVICIOS DE ALTA TECNOLOGÍA   (Panama)

^b UNIVERSITY OF NEW ORLEANS   (United States)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Behavior; Dopamine receptor; Mutant mice; Rhes protein; Sexes

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; RAS HOMOLOG ENRICHED IN STRIATUM PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; FEMALE; HETEROZYGOSITY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; OPEN FIELD BEHAVIOR; PROTEIN EXPRESSION; SEX DIFFERENCE; STEREOTYPY; TRANQUILIZING ACTIVITY; WILD TYPE;

EID: 84856200717     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/ndt.s25888     Document Type: Article

References (44)

1. Goldman-Rakic PS, Selemon LD. New frontiers in basal ganglia research. Introduction. Trends Neurosci. 1990;13(7):241-244.
2. Sibley DR, Monsma FJ Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci. 1992;13(2):61-69.
3. LaHoste GJ, Henry BL, Marshall JF. Dopamine D1 receptors synergize with D2, but not D3 or D4, receptors in the striatum without the involvement of action potentials. J Neurosci. 2000;20(17):6666-6671.
4. O'Sullivan GJ, Kinsella A, Grandy DK, Tighe O, Croke DT, Waddington JL. Ethological resolution of behavioral topography and D2-like vs D1-like agonist responses in congenic D4 dopamine receptor "knockouts": identification of D4:D1-like interactions. Synapse. 2006;59(2):107-118.
5. Braun AR, Chase TN. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. Eur J Pharmacol. 1986;131(2-3):301-306.
6. Lahoste GJ, Marshall JF. Dopamine receptor interactions in the brain. In: Stone TW, editor. CNS Neurotransmitters and Neuromodulators: Dopamine. Boca Raton, FL: CRC Press; 1996:107-119.
7. Bordi F, Meller E. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats. Brain Res. 1989;504(2):276-283.
8. Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Science. 1987;236(4802):719-722.
9. White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol Biochem Behav. 1988;30(1):189-193.
10. LaHoste GJ, Yu J, Marshall JF. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci U S A. 1993;90(16):7451-7455.
11. Deng YP, Lei WL, Reiner A. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat. 2006;32(2-4):101-116.
12. Arnt J. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions. Life Sci. 1985;37(8):717-723.
13. Arnt J, Hyttel J. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. Eur J Pharmacol. 1984;102(2):349-354.
14. Hu XT, Wachtel SR, Galloway MP, White FJ. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. J Neurosci. 1990;10(7):2318-2329.
15. LaHoste GJ, Marshall JF. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density. Synapse. 1992;12(1):14-26.
16. Falk JD, Vargiu P, Foye PE, et al. Rhes: A striatal-specific Ras homolog related to Dexras1. J Neurosci Res. 1999;57(6):782-788.
17. Harrison LM, LaHoste GJ. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. Neuroscience. 2006;137(2):483-492.
18. Vargiu P, De Abajo R, Garcia-Ranea JA, et al. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene. 2004;23(2):559-568.
19. Harrison LM, Lahoste GJ, Ruskin DN. Ontogeny and dopaminergic regulation in brain of ras homolog enriched in striatum (Rhes). Brain Res. 2008;1245:16-25.
20. Errico F, Santini E, Migliarini S, et al. The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Mol Cell Neurosci. 2008;37(2):335-345.
21. Cismowski MJ, Ma C, Ribas C, et al. Activation of heterotrimeric G-protein signaling by a ras-related protein. Implications for signal integration. J Biol Chem. 2000;275(31):23421-23424.
22. Graham TE, Prossnitz ER, Dorin RI. Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases. J Biol Chem. 2002;277(13):10876-10882.
23. Harrison LM, He Y. Rhes and AGS1/Dexras1 affect signaling by dopamine D1 receptors through adenylyl cyclase. J Neurosci Res. 2011;89(6):874-882.
24. Thapliyal A, Bannister RA, Hanks C, Adams BA. The monomeric G proteins AGS1 and Rhes selectively influence Galphai-dependent signaling to modulate N-type (CaV2.2) calcium channels. Am J Physiol Cell Physiol. 2008;295(5):C1417-C1426.
25. Quintero GC, Spano D, Lahoste GJ, Harrison LM. The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice. Neuroreport. 2008;19(16):1563-1566.
26. Spano D, Branchi I, Rosica A, et al. Rhes is involved in striatal function. Mol Cell Biol. 2004;24(13):5788-5796.
27. Nolan EB, Harrison LM, Lahoste GJ, Ruskin DN. Behavioral synergism between D(1) and D(2) dopamine receptors in mice does not depend on gap junctions. Synapse. 2007;61(5):279-287.
28. Holmes A, Kinney JW, Wrenn CC, et al. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology. 2003;28(6):1031-1044.
29. Angrist B, Thompson H, Shopsin B, Gershon S. Clinical studies with dopamine-receptor stimulants. Psychopharmacologia. 1975;44(3):273-280.
30. Corsini GU, Del Zompo M, Manconi S, Piccardi MP, Onali PL, Mangoni A. Evidence for dopamine receptors in the human brain mediating sedation and sleep. Life Sci. 1977;20(9):1613-1618.
31. Douglas CJ. Delirium tremens. New York Medical Journal. 1900:72.
32. Douglas CJ. A prompt emergency hypnotic. New York Medical Journal. 1917;106:1032.
33. Lal S, De la Vega CE. Apomorphine and psychopathology. J Neurol Neurosurg Psychiatry. 1975;38(7):722-726.
34. Kestler LP, Malhotra AK, Finch C, Adler C, Breier A. The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised. Neuropsychiatry Neuropsychol Behav Neurol. 2000;13(1):48-52.
35. Laakso A, Wallius E, Kajander J, et al. Personality traits and striatal dopamine synthesis capacity in healthy subjects. Am J Psychiatry. 2003;160(5):904-910.
36. Goldberg HL, Finnerty RJ. The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry. 1979;136(9):1184-1187.
37. Wacker J, Reuter M, Hennig J, Stemmler G. Sexually dimorphic link between dopamine D2 receptor gene and neuroticism-anxiety. Neuroreport. 2005;16(6):611-614.
38. Savageau MM, Beatty WW. Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats. Pharmacol Biochem Behav. 1981;14(1):17-21.
39. Walker QD, Cabassa J, Kaplan KA, et al. Sex differences in cocainestimulated motor behavior: disparate effects of gonadectomy. Neuropsychopharmacology. 2001;25(1):118-130.
40. Miller JC. Sex differences in dopaminergic and cholinergic activity and function in the nigro-striatal system of the rat. Psychoneuroendocrinology. 1983;8(2):225-236.
41. Van Hartesveldt C, Joyce JN. Effects of estrogen on the basal ganglia. Neurosci Biobehav Rev. 1986;10(1):1-14.
42. Camp DM, Robinson TE. Susceptibility to sensitization. II. The influence of gonadal hormones on enduring changes in brain monoamines and behavior produced by the repeated administration of D-amphetamine or restraint stress. Behav Brain Res. 1988;30(1):69-88.
43. Quiñones-Jenab V, Ho A, Schlussman SD, Franck J, Kreek MJ. Estrous cycle differences in cocaine-induced stereotypic and locomotor behaviors in Fischer rats. Behav Brain Res. 1999;101(1):15-20.
44. Becker JB, Cha JH. Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysis. Behav Brain Res. 1989;35(2):117-125.